Navigation Links
Life Technologies Develops Potent Drug Delivery Technology for Therapeutics Market
Date:7/14/2011

CARLSBAD, Calif., July 14, 2011 /PRNewswire/ -- Life Technologies Corporation today announced that it has developed new drug delivery technology specially designed for therapeutic applications that is 100-fold more potent than previous formulations. The technology is available for licensing as part of a new out-licensing program.

Scientists at Life Technologies have developed the novel proprietary siRNA delivery reagents by using new lipid molecules and formulation design to drastically improve potency and minimize toxicity in vivo. A single dose of 12.5ug siRNA per kilogram can achieve 50 percent knock down of a target gene, said Keith Farnsworth, product management leader at Life Technologies.

"Historically, delivery of siRNA has been problematic due to the high risk of toxicity and hampered efficiency," he said. "Life Technologies' new formulations provide the pharmaceutical and biotech industries a viable platform to help develop siRNA drugs that overcome these challenges."

The availability of the new formulations follows Life Technologies' 2010 launch of Invivofectamine 2.0®, a lipid-based siRNA delivery technology for the research market that can knock down up to four genes in vivo in lab models for extended periods with a single application. The novel formulations available through the out-licensing program use different molecules that make it ideal for therapeutic applications.

For more information, contact Maya Tanaka, Sr. Manager, Business Development and Licensing, (760) 268-7982; Maya.Tanaka@lifetech.com

About Life Technologies (www.lifetechn
'/>"/>

SOURCE Life Technologies Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Double Eagle Holdings Enters Into Supply Agreement with Platform Delivery Technologies Inc.
2. IDEV Technologies Launches Lower Profile SUPERA VERITAS® Stent Delivery System
3. Life Technologies Sets 2nd Quarter 2011 Earnings Release Date for Thursday, July 28, 2011
4. Flow Cytometry: Products, Technologies and Global Markets
5. Micell Technologies Announces Reduced Clinical Trial Sample Size for MiStent® Drug-Eluting Coronary Stent Based on Early Clinical Data
6. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
7. Althea Technologies Receives FDA Approval to Initiate Commercial Manufacturing
8. Global Technologies, Ltd. Announces LOI to Acquire and Merge with Oxygen Orchard, Inc.
9. Alan Dunton, M.D., Joins Board of Directors of Palatin Technologies, Inc.
10. Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K.
11. China Medical Technologies Announces Strategic Collaboration Between its Subsidiary, GP Medical, and Da An Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... /PRNewswire-iReach/ -- Gateway Analytical announced today that they ... Annual Global Pharma Manufacturing Summit in ... The Global Pharma Manufacturing Summit offers a networking ... biologic pharmaceutical manufacturing. The conference is focused on ... such as the increasing pressure to grow and ...
(Date:8/28/2014)... Orthopaedics, the Official Joint Replacement Products of the PGA TOUR ... to golf fans at the next stop of the FedEx ... company,s fan destination – "The Stryker Mobility Zone" – will ... TPC Boston in Norton, MA starting ... the Deutsche Bank Championship, Stryker will be providing golf fans ...
(Date:8/28/2014)... NEW YORK , Aug. 28, ... a new market research report is ... ADHD Therapeutics to 2020 - Broadened ... to Drive Market Growth despite Patent ... ADHD Therapeutics to ...
Breaking Medicine Technology:Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 2Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 3Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 4Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 5ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 2ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 3ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 4ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 5ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 6ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 7ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 8
(Date:8/29/2014)... CA (PRWEB) August 29, 2014 According ... a lawsuit against Pfizer Inc., Greenstone LLC and Pfizer ... with congenital birth defects as a result of ... defect lawsuit was filed in St. Clair County Circuit ... to the lawsuit, the defendant companies allegedly concealed the ...
(Date:8/29/2014)... 2014 Under Section 946.300, Qualifications for ... “The physician shall not…advertise in a cultivation center or ... What the state of Illinois has done is create ... potential patients entering their care. The goal is to ... pharmacies and with typical prescription medications. Medical steering is ...
(Date:8/28/2014)... FL (PRWEB) August 29, 2014 ... that brings pharmaceutical industry precision to the development ... zoning approval for its primary location in Sarasota ... and decisively with a total commitment to attracting ... forward to creating," says David Wright, President and ...
(Date:8/28/2014)... Arlington, Massachusetts (PRWEB) August 29, 2014 ... company that solves some of the healthcare industry's ... design concepts that radically rethink health. Involution ... edge of technology creating software solutions for clients ... and Walgreens. , As part of the studio's ...
(Date:8/28/2014)... UWDress.com, an internationally famous designer and leader ... fashionable assortment of fall bridesmaid dresses for ... customers, the company is now providing big discounts for ... fall bridesmaid outfits are offered in many fashionable colours. ... priced less than $190. UWDress.com’s kind officials always take ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Zoloft Birth Defect Lawsuit 2Health News:Medical Marijuana Company Provides Solution for Illinois Marketing Regulations 2Health News:Sarasota County Approves Zoning for Leading Medical Cannabis Firm AltMed 2Health News:Top Three Open Source Design Concepts that Rethink Health from Involution Studios 2Health News:Top Three Open Source Design Concepts that Rethink Health from Involution Studios 3Health News:Fashionable Fall Bridesmaid Dresses From UWDress.com 2
... primary biliary cirrhosis may lead to new treatments, researchers ... have found genetic variations that appear to increase the ... that can destroy the liver. , Primary biliary cirrhosis ... in the liver. It is a condition that mostly ...
... BEER-SHEVA, ISRAEL, June 10, 2009 Metoclopramide, a drug approved ... significant risks for the fetus according to a large cohort ... New England Journal of Medicine , "The Safety of ... Engl J Med 2009;360:24 June 11, 2009). According ...
... , WASHINGTON, June 10 Trust for America,s Health (TFAH) ... and Pensions (HELP) for including strong prevention and public health ... health of Americans. , , "Our nation will ... do a better job of keeping Americans healthier and preventing ...
... Survey Conducted with American Dietetic Association Shows Lack of Reimbursement ... June 10 Ninety-six percent of primary care physicians believe ... nutrition to treat and manage chronic disease, according to a ... currently pay significant attention to nutrition in the context of ...
... Researchers at The Wistar Institute have defined a key ... process of aging. The study, published June 11 in ... of aging that could point toward new anti-aging strategies ... that a class of proteins called sirtuins promotes fitness ...
... 10 RPD Media Associates, LLC, a full-service video content marketing ... , , ACW recognized RPD Media for producing: an ... Westchester Orthopaedic Institute; a radio spot series for WHUD ... Minute ; a feature film for The Snowball Gala ...
Cached Medicine News:Health News:Genetic Links to Rare Liver Disease Found 2Health News:Genetic Links to Rare Liver Disease Found 3Health News:Off-label morning sickness drug deemed safe for fetuses -- Ben-Gurion U. researchers 2Health News:TFAH Applauds 'Affordable Health Choices Act' for Making Prevention a Cornerstone of Health Reform 2Health News:TFAH Applauds 'Affordable Health Choices Act' for Making Prevention a Cornerstone of Health Reform 3Health News:TFAH Applauds 'Affordable Health Choices Act' for Making Prevention a Cornerstone of Health Reform 4Health News:More Than 9 in 10 Primary Care Physicians Say U.S. Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 2Health News:More Than 9 in 10 Primary Care Physicians Say U.S. Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 3Health News:More Than 9 in 10 Primary Care Physicians Say U.S. Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 4Health News:Wistar Institute team finds key target of aging regulator 2Health News:RPD Media Wins Four 'Big W' Awards by the Advertising Club of Westchester County 2
Intended for the quantitative determination of creatinine in serum, plasma, or urine. Reaction: Endpoint. Wavelength: 340 nm. Linearity: 10 mg/dL (880 mol/L). Two vials, dry powder reagents....
For the qualitative determination of magnesium in serum....
Intended for the quantitative determination of magnesium in serum. Wavelength: 340 nm. Linearity: 9.7 mg/dL (4 mmol/L). Two vials, dry powder reagents....
For the quantitative determination of total glucose in serum....
Medicine Products: